Kavanagh, Kevin

Histatins: Antimicrobial peptides with therapeutic potential

Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology

Antimicrobial Peptides and ActivitiesAntifungal resistance and susceptibility

Cited by 223

Emergence of Saccharomyces cerevisiae as a human pathogen

Murphy, A., & Kavanagh, K. (1999) · Enzyme and Microbial Technology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 98

A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in Aspergillus fumigatus

Reeves, E. P., Reiber, K., Neville, C., Scheibner, O., Kavanagh, K., & Doyle, S. (2006) · The FEBS Journal

Microbial Natural Products and BiosynthesisFungal and yeast genetics research

Cited by 70

Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B

Geraghty, P., & Kavanagh, K. (2003) · Archives of Microbiology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 45

Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans

Geraghty, P., & Kavanagh, K. (2003) · Journal of Pharmacy and Pharmacology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 23

Assessment of the in vitro and in vivo activity of atorvastatin against Candida albicans.

Ajdidi, A., Sheehan, G., Abu Elteen, K., & Kavanagh, K. (2019) · Journal of medical microbiology

Antimicrobial Peptides and ActivitiesPeptidase Inhibition and Analysis

Cited by 18